Implementation of whole-genome and transcriptome sequencing into clinical cancer care
E Cuppen, O Elemento, R Rosenquist, S Nikic… - JCO Precision …, 2022 - ascopubs.org
PURPOSE The combination of whole-genome and transcriptome sequencing (WGTS) is
expected to transform diagnosis and treatment for patients with cancer. WGTS is a …
expected to transform diagnosis and treatment for patients with cancer. WGTS is a …
[HTML][HTML] Therapeutic and prognostic insights from the analysis of cancer mutational signatures
The somatic mutations in each cancer genome are caused by multiple mutational
processes, each of which leaves a characteristic imprint (or 'signature'), potentially caused …
processes, each of which leaves a characteristic imprint (or 'signature'), potentially caused …
Genomes for kids: the scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing
S Newman, J Nakitandwe, CA Kesserwan, EM Azzato… - Cancer discovery, 2021 - AACR
Genomic studies of pediatric cancer have primarily focused on specific tumor types or high-
risk disease. Here, we used a three-platform sequencing approach, including whole …
risk disease. Here, we used a three-platform sequencing approach, including whole …
[HTML][HTML] Pan-cancer landscape of homologous recombination deficiency
L Nguyen, J WM Martens, A Van Hoeck… - Nature …, 2020 - nature.com
Homologous recombination deficiency (HRD) results in impaired double strand break repair
and is a frequent driver of tumorigenesis. Here, we develop a genome-wide mutational scar …
and is a frequent driver of tumorigenesis. Here, we develop a genome-wide mutational scar …
A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies
A Degasperi, TD Amarante, J Czarnecki, S Shooter… - Nature cancer, 2020 - nature.com
Mutational signatures are patterns of mutations that arise during tumorigenesis. We present
an enhanced, practical framework for mutational signature analyses. Applying these …
an enhanced, practical framework for mutational signature analyses. Applying these …
Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice
KG Samsom, LJ Schipper, P Roepman… - The Journal of …, 2022 - Wiley Online Library
The current increase in number and diversity of targeted anticancer agents poses
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in …
[HTML][HTML] The mutational signatures of formalin fixation on the human genome
Clinical archives of patient material near-exclusively consist of formalin-fixed and paraffin-
embedded (FFPE) blocks. The ability to precisely characterise mutational signatures from …
embedded (FFPE) blocks. The ability to precisely characterise mutational signatures from …
Analysis of mutational signatures with yet another package for signature analysis
D Hübschmann, L Jopp‐Saile… - Genes …, 2021 - Wiley Online Library
Different mutational processes leave characteristic patterns of somatic mutations in the
genome that can be identified as mutational signatures. Determining the contributions of …
genome that can be identified as mutational signatures. Determining the contributions of …
Undifferentiated and dedifferentiated metastatic melanomas masquerading as soft tissue sarcomas: mutational signature analysis and immunotherapy response
IS Kasago, WK Chatila, CM Lezcano… - Modern Pathology, 2023 - Elsevier
The distinction between undifferentiated melanoma (UM) or dedifferentiated melanoma
(DM) from undifferentiated or unclassifiable sarcoma can be difficult and requires the careful …
(DM) from undifferentiated or unclassifiable sarcoma can be difficult and requires the careful …
[HTML][HTML] The DNA damage response pathway as a land of therapeutic opportunities for colorectal cancer
Background Colorectal cancer (CRC) represents a major cause of cancer deaths worldwide.
Although significant progress has been made by molecular and immune therapeutic …
Although significant progress has been made by molecular and immune therapeutic …